Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-α (C/EBPα), in acute myeloid leukemia
By T. Pabst, B. Mueller, Pu Zhang, H. Radomska, S. Narravula, S. Schnittger, G. Behre, W. Hiddemann, Daniel G. Tenen. Nature Genetics, 2001
848 citations recorded by the source corpus.
Subfields: Genetics, Hematology
View Paper: https://www.semanticscholar.org/paper/9e8ebee8eece81947dab2deda877cfda4bdbb3cc
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Genetics
In Hematology
Citations in the corpus
- Hematopoiesis: an evolving paradigm for stem cell biology. (2008, background): “1 and C/EBPa in myeloid leukemias (Mueller et al., 2002; Pabst et al., 2001), and Pax5 and other B cell factors (for example, E2A and EBF) in B-lymphoid leukemias (Mullighan et al.”